Centene Corporation (CNC)
USD 60.16
(1.26%)
USD 60.16
(1.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.61 Billion USD | -43.53% |
| 2022 | 4.05 Billion USD | 9.5% |
| 2021 | 3.95 Billion USD | 7.39% |
| 2020 | 4.76 Billion USD | 63.75% |
| 2019 | 2.83 Billion USD | 37.99% |
| 2018 | 2.2 Billion USD | 25.19% |
| 2017 | 1.75 Billion USD | 1.43% |
| 2016 | 1.65 Billion USD | 88.48% |
| 2015 | 851 Million USD | 47.56% |
| 2014 | 581 Million USD | 60.37% |
| 2013 | 354.59 Million USD | 416.39% |
| 2012 | 66.77 Million USD | -73.14% |
| 2011 | 248.65 Million USD | 18.93% |
| 2010 | 224.27 Million USD | 14.79% |
| 2009 | 182.13 Million USD | 9.08% |
| 2008 | 166.97 Million USD | 103.88% |
| 2007 | 81.9 Million USD | 1085.8% |
| 2006 | 9.58 Million USD | -109.0% |
| 2005 | 102.91 Million USD | 23.76% |
| 2004 | 74.55 Million USD | 54.62% |
| 2003 | 48.21 Million USD | 113.59% |
| 2002 | 43.74 Million USD | -39.85% |
| 2001 | 20.31 Million USD | -4141.86% |
| 2000 | 7.55 Million USD | 194.95% |
| 1999 | -6.61 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.53 Billion USD | 1.99% |
| 2024 Q1 | 1.42 Billion USD | 275.29% |
| 2024 Q3 | 1.41 Billion USD | -29.43% |
| 2023 FY | - USD | -43.53% |
| 2023 Q4 | -194 Million USD | -126.39% |
| 2023 Q2 | 1.17 Billion USD | -26.07% |
| 2023 Q1 | 1.58 Billion USD | 144.07% |
| 2023 Q3 | 735 Million USD | -37.23% |
| 2022 Q2 | 1.71 Billion USD | 4.56% |
| 2022 Q1 | 1.64 Billion USD | 67.48% |
| 2022 FY | - USD | 9.5% |
| 2022 Q4 | 649 Million USD | -43.86% |
| 2022 Q3 | 1.15 Billion USD | -32.71% |
| 2021 FY | - USD | 7.39% |
| 2021 Q3 | 1.15 Billion USD | 13.24% |
| 2021 Q1 | 1.41 Billion USD | 583.57% |
| 2021 Q2 | 1.02 Billion USD | -27.92% |
| 2021 Q4 | 981 Million USD | -15.06% |
| 2020 Q2 | 2.34 Billion USD | 328.47% |
| 2020 Q3 | 1.15 Billion USD | -50.64% |
| 2020 Q4 | 207 Million USD | -82.14% |
| 2020 FY | - USD | 63.75% |
| 2020 Q1 | 548 Million USD | 60.7% |
| 2019 Q3 | 609 Million USD | -23.97% |
| 2019 Q1 | 840 Million USD | 86.67% |
| 2019 Q2 | 801 Million USD | -4.64% |
| 2019 FY | - USD | 37.99% |
| 2019 Q4 | 341 Million USD | -44.01% |
| 2018 Q2 | 600 Million USD | -6.83% |
| 2018 Q4 | 450 Million USD | 150.0% |
| 2018 FY | - USD | 25.19% |
| 2018 Q1 | 644 Million USD | 192.73% |
| 2018 Q3 | 180 Million USD | -70.0% |
| 2017 Q3 | 431 Million USD | -17.9% |
| 2017 FY | - USD | 1.43% |
| 2017 Q1 | 326 Million USD | -46.56% |
| 2017 Q2 | 525 Million USD | 61.04% |
| 2017 Q4 | 220 Million USD | -48.96% |
| 2016 FY | - USD | 88.48% |
| 2016 Q4 | 610 Million USD | 58.44% |
| 2016 Q3 | 385 Million USD | -15.01% |
| 2016 Q2 | 453 Million USD | 723.64% |
| 2016 Q1 | 55 Million USD | -75.0% |
| 2015 Q1 | 156 Million USD | -19.59% |
| 2015 Q2 | 199 Million USD | 27.56% |
| 2015 Q4 | 220 Million USD | 3.77% |
| 2015 FY | - USD | 47.56% |
| 2015 Q3 | 212 Million USD | 6.53% |
| 2014 Q2 | 114.45 Million USD | 26.68% |
| 2014 Q4 | 194 Million USD | 48.27% |
| 2014 Q1 | 90.35 Million USD | -11.67% |
| 2014 FY | - USD | 60.37% |
| 2014 Q3 | 130.83 Million USD | 14.31% |
| 2013 FY | - USD | 416.39% |
| 2013 Q2 | 84.26 Million USD | 51.02% |
| 2013 Q3 | 82.23 Million USD | -2.41% |
| 2013 Q4 | 102.28 Million USD | 24.39% |
| 2013 Q1 | 55.79 Million USD | 326.96% |
| 2012 Q4 | 13.06 Million USD | 218.64% |
| 2012 Q2 | -14.66 Million USD | -128.87% |
| 2012 FY | - USD | -73.14% |
| 2012 Q3 | -11.01 Million USD | 24.9% |
| 2012 Q1 | 50.81 Million USD | 7.25% |
| 2011 Q3 | 63.03 Million USD | -9.36% |
| 2011 Q1 | 57.17 Million USD | -2.9% |
| 2011 Q2 | 69.54 Million USD | 21.64% |
| 2011 Q4 | 47.37 Million USD | -24.84% |
| 2011 FY | - USD | 18.93% |
| 2010 Q1 | 42.13 Million USD | -17.35% |
| 2010 FY | - USD | 14.79% |
| 2010 Q3 | 53.95 Million USD | -0.28% |
| 2010 Q2 | 54.1 Million USD | 28.39% |
| 2010 Q4 | 58.88 Million USD | 9.14% |
| 2009 Q1 | 41.14 Million USD | -5.43% |
| 2009 Q4 | 50.98 Million USD | 6.39% |
| 2009 Q3 | 47.91 Million USD | 13.84% |
| 2009 Q2 | 42.09 Million USD | 2.31% |
| 2009 FY | - USD | 9.08% |
| 2008 FY | - USD | 103.88% |
| 2008 Q4 | 43.5 Million USD | 32.37% |
| 2008 Q3 | 32.86 Million USD | -8.9% |
| 2008 Q2 | 36.08 Million USD | -19.33% |
| 2008 Q1 | 44.72 Million USD | 906.48% |
| 2007 Q1 | 23.42 Million USD | 116.97% |
| 2007 Q2 | 23.58 Million USD | 0.67% |
| 2007 FY | - USD | 1085.8% |
| 2007 Q3 | 30.45 Million USD | 29.13% |
| 2007 Q4 | 4.44 Million USD | -85.41% |
| 2006 Q1 | 13.57 Million USD | -56.61% |
| 2006 Q4 | -138.06 Million USD | -226.96% |
| 2006 Q3 | 108.74 Million USD | 1362.43% |
| 2006 Q2 | 7.43 Million USD | -45.23% |
| 2006 FY | - USD | -109.0% |
| 2005 Q3 | 16.07 Million USD | -29.84% |
| 2005 Q2 | 22.91 Million USD | 4.26% |
| 2005 Q1 | 21.98 Million USD | -11.26% |
| 2005 FY | - USD | 23.76% |
| 2005 Q4 | 31.28 Million USD | 94.57% |
| 2004 Q3 | 17.3 Million USD | 1.61% |
| 2004 Q4 | 24.76 Million USD | 43.12% |
| 2004 FY | - USD | 54.62% |
| 2004 Q1 | 15.44 Million USD | 8.24% |
| 2004 Q2 | 17.03 Million USD | 10.27% |
| 2003 Q1 | 11.52 Million USD | 102.85% |
| 2003 Q2 | 10.33 Million USD | -0.86% |
| 2003 Q3 | 12.64 Million USD | 23.63% |
| 2003 Q4 | 15.95 Million USD | 10.33% |
| 2003 FY | - USD | 113.59% |
| 2002 FY | - USD | -39.85% |
| 2002 Q4 | -368.83 Million USD | -20427.38% |
| 2002 Q3 | 8.02 Million USD | -74.88% |
| 2002 Q2 | 7.71 Million USD | 24.35% |
| 2002 Q1 | 6.73 Million USD | 0.0% |
| 2001 FY | - USD | -4141.86% |
| 2000 FY | - USD | 194.95% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cigna Corporation | 9.98 Billion USD | 43.767% |
| CVS Health Corporation | 18.17 Billion USD | 69.106% |
| Elevance Health Inc. | 10.49 Billion USD | 46.463% |
| Humana Inc. | 4.93 Billion USD | -13.915% |
| Molina Healthcare, Inc. | 1.74 Billion USD | -222.018% |
| Oscar Health, Inc. | -212 Million USD | 2749.019% |
| UnitedHealth Group Incorporated | 36.33 Billion USD | 84.542% |